Sagami Rubber Industries Co., Ltd. engages primarily in the manufacture and sale of condoms, plastic films, and healthcare products. Its main product categories include ultra-thin polyurethane condoms under the Sagami Original brand, colored and dotted condoms, medical rubber products such as probe covers and external catheters (Urosheaths), and plastic products encompassing office files and food packaging films. The company also offers bathing services and various daily essential items. Sagami operates mainly in Japan and serves both domestic and international markets. Founded in 1934 and headquartered in Tokyo, Japan, Sagami Rubber Industries is recognized as Japan’s first latex condom manufacturer and a pioneer in condom innovation globally.
In the last 1-2 years, Sagami Rubber Industries has seen strategic developments including maintaining its position as a global leader in polyurethane condom technology, expanding its healthcare product lines, and enhancing its plastic product offerings. Recent financial reports show adjustments in revenue and operational performance as the company responds to evolving market demands and economic conditions. There have been no recent significant mergers or acquisitions publicly disclosed as of late 2025, but the company continues to invest in R&D and product innovation to sustain growth and competitive advantage in its core segments.
Sagami Rubber Industries operates within the healthcare, consumer goods, and specialty plastics industries. Its customer base includes healthcare providers, retailers, and consumers seeking quality protective and healthcare-related products. The company's comprehensive portfolio and ongoing innovation efforts underpin its position in the global rubber and healthcare markets, supporting sustained market presence and competitiveness.
This description reflects Sagami Rubber Industries’ comprehensive product scope, recent operational focus, and its historic and ongoing industry contributions within Japan and internationally.